Related Experiment Video

Updated: May 26, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

Overexpression of the Notch3 receptor in non-functioning pituitary tumours

Zengli Miao1, Yifeng Miao, Yuchang Lin

  • 1Neuroscience Center, Nanjing Medical University, Affiliated with Wuxi No 2 Hospital, 68 Zhongshan Road, Wuxi 214002, China. drmiao858@sina.com

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|December 14, 2011
PubMed

Insights

Overexpression of Notch3 in non-functioning pituitary adenomas suggests it drives tumor growth. This finding implicates the Notch3 pathway as a potential therapeutic target for these tumors.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Non-functioning pituitary adenomas (NFAs) lack effective medical treatments.
  • These tumors can cause hypopituitarism or compress surrounding tissues.
  • The Notch3 pathway is implicated in NFA progression.

Purpose of the Study:

  • To investigate the role of Notch3 in the pathogenesis of human non-functioning pituitary adenomas.
  • To analyze Notch3 mRNA and protein expression levels in NFAs compared to normal pituitary tissue.

Main Methods:

  • Reverse transcriptase-polymerase chain reaction (RT-PCR) to quantify Notch3 mRNA.
  • Western blotting to assess Notch3 protein levels.
  • Immunohistochemistry to localize Notch3 expression within pituitary cells.

Main Results:

  • Notch3 mRNA was significantly upregulated in NFAs.
  • Notch3 protein expression was higher in NFAs than in normal pituitary tissue.
  • Notch3 was highly expressed in the cytoplasm of NFA cells.

Conclusions:

  • Overexpression of Notch3 mRNA and protein may contribute to NFA growth.
  • This study provides the first comprehensive analysis of Notch3 in NFAs.
  • The Notch3 pathway represents a potential molecular therapeutic target for NFA treatment.

More Related Videos

Stimulation of Notch Signaling in Mouse Osteoclast Precursors08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...